{
    "organizations": [],
    "uuid": "dedb4f744b657ab2a953332c52a0caa56c3a4726",
    "author": "",
    "url": "https://www.reuters.com/article/brief-biocryst-pharma-and-idera-pharma-s/brief-biocryst-pharma-and-idera-pharma-sign-merger-agreement-to-form-new-company-idUSFWN1PH0OA",
    "ord_in_thread": 0,
    "title": "BRIEF-Biocryst Pharma And Idera Pharma Sign Merger Agreement To Form New Company",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 22, 2018 / 1:55 PM / in 6 minutes BRIEF-Biocryst Pharma And Idera Pharma Sign Merger Agreement To Form New Company Reuters Staff 2 Min Read \nJan 22 (Reuters) - Biocryst Pharmaceuticals Inc: \n* BIOCRYST PHARMACEUTICALS AND IDERA PHARMACEUTICALS ANNOUNCE MERGER TO COMBINE CAPABILITIES TO SERVE MORE PATIENTS WITH RARE DISEASES \n* IDERA PHARMACEUTICALS INC - ‍MERGER AGREEMENT HAS BEEN UNANIMOUSLY APPROVED BY BOARDS OF DIRECTORS OF BOTH COMPANIES​ \n* IDERA PHARMACEUTICALS INC - ROBERT INGRAM TO BE CHAIRMAN OF BOARD, VINCENT MILANO TO BE CEO OF COMBINED COMPANY \n* IDERA PHARMACEUTICALS - UNDER TERMS OF MERGER AGREEMENT, EACH SHARE OF BIOCRYST COMMON STOCK WILL BE EXCHANGED FOR 0.50 SHARES OF NEW COMPANY STOCK \n* IDERA PHARMACEUTICALS - UNDER TERMS OF MERGER AGREEMENT, EACH SHARE OF IDERA COMMON STOCK WILL BE EXCHANGED FOR 0.20 SHARES OF NEW COMPANY STOCK \n* IDERA PHARMACEUTICALS - ‍SIGNIFICANT STOCKHOLDER OF CO, BIOCRYST AGREED TO ENTER VOTING AND SUPPORT AGREEMENT AND HAS AGREED TO VOTE IN FAVOR OF DEAL​ \n* IDERA PHARMACEUTICALS INC - AFTER DEAL BIOCRYST STOCKHOLDERS WILL OWN 51.6 PERCENT OF STOCK OF COMBINED COMPANY, CO‘S STOCKHOLDERS TO OWN 48.4 PERCENT \n* IDERA PHARMACEUTICALS - COMBINED COMPANY, WHICH WILL BE RENAMED POST-CLOSING, WILL BE HEADQUARTERED AT CURRENT IDERA HEADQUARTERS \n* IDERA PHARMACEUTICALS INC - STOCK ISSUANCE IN MERGER IS EXPECTED TO BE TAX-FREE TO STOCKHOLDERS Source text for Eikon: Further company coverage:",
    "published": "2018-01-22T15:54:00.000+02:00",
    "crawled": "2018-01-22T16:03:06.022+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "minute",
        "pharma",
        "idera",
        "pharma",
        "sign",
        "merger",
        "agreement",
        "form",
        "new",
        "company",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "biocryst",
        "pharmaceutical",
        "inc",
        "biocryst",
        "pharmaceutical",
        "idera",
        "pharmaceutical",
        "announce",
        "merger",
        "combine",
        "capability",
        "serve",
        "patient",
        "rare",
        "disease",
        "idera",
        "pharmaceutical",
        "inc",
        "agreement",
        "unanimously",
        "approved",
        "board",
        "director",
        "idera",
        "pharmaceutical",
        "inc",
        "robert",
        "ingram",
        "chairman",
        "board",
        "vincent",
        "milano",
        "ceo",
        "combined",
        "company",
        "idera",
        "pharmaceutical",
        "term",
        "merger",
        "agreement",
        "share",
        "biocryst",
        "common",
        "stock",
        "exchanged",
        "share",
        "new",
        "company",
        "stock",
        "idera",
        "pharmaceutical",
        "term",
        "merger",
        "agreement",
        "share",
        "idera",
        "common",
        "stock",
        "exchanged",
        "share",
        "new",
        "company",
        "stock",
        "idera",
        "pharmaceutical",
        "stockholder",
        "co",
        "biocryst",
        "agreed",
        "enter",
        "voting",
        "support",
        "agreement",
        "agreed",
        "vote",
        "favor",
        "idera",
        "pharmaceutical",
        "inc",
        "deal",
        "biocryst",
        "stockholder",
        "percent",
        "stock",
        "combined",
        "company",
        "co",
        "stockholder",
        "percent",
        "idera",
        "pharmaceutical",
        "combined",
        "company",
        "renamed",
        "headquartered",
        "current",
        "idera",
        "headquarters",
        "idera",
        "pharmaceutical",
        "inc",
        "stock",
        "issuance",
        "merger",
        "expected",
        "stockholder",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}